Kati Ylitalo

1.1k total citations
22 papers, 910 citations indexed

About

Kati Ylitalo is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Kati Ylitalo has authored 22 papers receiving a total of 910 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cardiology and Cardiovascular Medicine, 10 papers in Surgery and 9 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Kati Ylitalo's work include Diabetes, Cardiovascular Risks, and Lipoproteins (9 papers), Lipoproteins and Cardiovascular Health (8 papers) and Lipid metabolism and disorders (7 papers). Kati Ylitalo is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (9 papers), Lipoproteins and Cardiovascular Health (8 papers) and Lipid metabolism and disorders (7 papers). Kati Ylitalo collaborates with scholars based in Finland, United States and Poland. Kati Ylitalo's co-authors include Marja‐Riitta Taskinen, Ilpo Nuotio, Jorma Viikari, Päivi Pajukanta, Jukka T. Salonen, Christian Ehnholm, Kimmo Porkka, Leena Peltonen, Ming‐Lin Liu and Jussi Pihlajamäki and has published in prestigious journals such as Nature Genetics, Stroke and The American Journal of Human Genetics.

In The Last Decade

Kati Ylitalo

21 papers receiving 867 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kati Ylitalo Finland 16 365 356 312 232 212 22 910
Tetsu Ebara Japan 17 363 1.0× 261 0.7× 301 1.0× 97 0.4× 233 1.1× 28 805
T W de Bruin Netherlands 15 683 1.9× 416 1.2× 311 1.0× 116 0.5× 177 0.8× 16 1.0k
George J. Miller United Kingdom 16 240 0.7× 145 0.4× 153 0.5× 326 1.4× 206 1.0× 17 826
Changting Haudenschild United States 8 301 0.8× 424 1.2× 153 0.5× 61 0.3× 237 1.1× 11 728
Daniel Brun Canada 14 385 1.1× 424 1.2× 209 0.7× 89 0.4× 109 0.5× 25 873
JD Brunzell United States 13 758 2.1× 467 1.3× 766 2.5× 205 0.9× 285 1.3× 19 1.3k
Felicia Y. T. Yap Australia 12 495 1.4× 266 0.7× 102 0.3× 124 0.5× 209 1.0× 15 1.0k
Ugo Cavallari Italy 16 189 0.5× 219 0.6× 428 1.4× 148 0.6× 191 0.9× 30 967
Sabine Rütti Switzerland 11 247 0.7× 329 0.9× 80 0.3× 130 0.6× 230 1.1× 16 678
M. Poapst Canada 13 617 1.7× 412 1.2× 397 1.3× 61 0.3× 193 0.9× 13 922

Countries citing papers authored by Kati Ylitalo

Since Specialization
Citations

This map shows the geographic impact of Kati Ylitalo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kati Ylitalo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kati Ylitalo more than expected).

Fields of papers citing papers by Kati Ylitalo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kati Ylitalo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kati Ylitalo. The network helps show where Kati Ylitalo may publish in the future.

Co-authorship network of co-authors of Kati Ylitalo

This figure shows the co-authorship network connecting the top 25 collaborators of Kati Ylitalo. A scholar is included among the top collaborators of Kati Ylitalo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kati Ylitalo. Kati Ylitalo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ylitalo, Kati, et al.. (2005). Serious pregnancy complications in a patient with previously undiagnosed carnitine palmitoyltransferase 1 deficiency. American Journal of Obstetrics and Gynecology. 192(6). 2060–2062. 22 indexed citations
2.
Liu, Ming‐Lin, Kati Ylitalo, Riitta Salonen, Jukka T. Salonen, & Marja‐Riitta Taskinen. (2004). Circulating Oxidized Low-Density Lipoprotein and Its Association With Carotid Intima-Media Thickness in Asymptomatic Members of Familial Combined Hyperlipidemia Families. Arteriosclerosis Thrombosis and Vascular Biology. 24(8). 1492–1497. 68 indexed citations
3.
Liu, Ming‐Lin, Richard W. James, Kati Ylitalo, & Marja‐Riitta Taskinen. (2004). Associations between HDL oxidation and paraoxonase-1 and paraoxonase-1 gene polymorphisms in families affected by familial combined hyperlipidemia. Nutrition Metabolism and Cardiovascular Diseases. 14(2). 81–87. 9 indexed citations
4.
Alagona, C., Aino Soro, Jukka Westerbacka, et al.. (2003). Low HDL cholesterol concentration is associated with increased intima‐media thickness independent of arterial stiffness in healthy subjects from families with low HDL cholesterol. European Journal of Clinical Investigation. 33(6). 457–463. 25 indexed citations
5.
Ylitalo, Kati, Mikko Syvänne, Riitta Salonen, et al.. (2002). Carotid artery intima-media thickness in Finnish families with familial combined hyperlipidemia. Atherosclerosis. 162(1). 171–178. 19 indexed citations
6.
Soro, Aino, Päivi Pajukanta, Heidi E. Lilja, et al.. (2002). Genome Scans Provide Evidence for Low-HDL-C Loci on Chromosomes 8q23, 16q24.1-24.2, and 20q13.11 in Finnish Families. The American Journal of Human Genetics. 70(5). 1333–1340. 87 indexed citations
7.
Ylitalo, Kati, Ilpo Nuotio, Jorma Viikari, et al.. (2002). C3, hormone-sensitive lipase, and peroxisome proliferator-activated receptor [gamma ] expression in adipose tissue of familial combined hyperlipidemia patients. Metabolism. 51(5). 664–670. 10 indexed citations
8.
Vakkilainen, Juha, Päivi Pajukanta, Rita M. Cantor, et al.. (2002). Genetic influences contributing to LDL particle size in familial combined hyperlipidaemia. European Journal of Human Genetics. 10(9). 547–552. 12 indexed citations
9.
Liu, Ming‐Lin, Kati Ylitalo, Juha Vakkilainen, et al.. (2002). Susceptibility of LDL to oxidation in vitro and antioxidant capacity in familial combined hyperlipidemia: comparison of patients with different lipid phenotypes. Annals of Medicine. 34(1). 48–54. 18 indexed citations
10.
Mäkimattila, Sari, Kati Ylitalo, A Schlenzka, et al.. (2002). Family histories of Type II diabetes and hypertension predict intima–media thickness in patients with Type I diabetes. Diabetologia. 45(5). 711–718. 22 indexed citations
11.
Lilja, Heidi E., Aino Soro, Kati Ylitalo, et al.. (2002). A candidate gene study in low HDL-cholesterol families provides evidence for the involvement of the APOA2 gene and the APOA1C3A4 gene cluster. Atherosclerosis. 164(1). 103–111. 17 indexed citations
12.
Alagona, C., Aino Soro, Kati Ylitalo, et al.. (2002). A low high density lipoprotein (HDL) level is associated with carotid artery intima-media thickness in asymptomatic members of low HDL families. Atherosclerosis. 165(2). 309–316. 31 indexed citations
13.
Vakkilainen, Juha, Matti Jauhiainen, Kati Ylitalo, et al.. (2002). LDL particle size in familial combined hyperlipidemia: effects of serum lipids, lipoprotein-modifying enzymes, and lipid transfer proteins. Journal of Lipid Research. 43(4). 598–603. 55 indexed citations
14.
Ylitalo, Kati, Päivi Pajukanta, Seppo Meri, et al.. (2001). Serum C3 but Not Plasma Acylation-Stimulating Protein Is Elevated in Finnish Patients With Familial Combined Hyperlipidemia. Arteriosclerosis Thrombosis and Vascular Biology. 21(5). 838–843. 30 indexed citations
15.
Ylitalo, Kati. (2001). Pathophysiology of adipose tissue metabolism and atherosclerosis in familial combined hyperlipidemia. Työväentutkimus Vuosikirja.
16.
Ylitalo, Kati, V. Large, Päivi Pajukanta, et al.. (2000). Reduced hormone-sensitive lipase activity is not a major metabolic defect in Finnish FCHL families. Atherosclerosis. 153(2). 373–381. 13 indexed citations
17.
Pajukanta, Päivi, Joseph D. Terwilliger, Markus Perola, et al.. (1999). Genomewide Scan for Familial Combined Hyperlipidemia Genes in Finnish Families, Suggesting Multiple Susceptibility Loci Influencing Triglyceride, Cholesterol, and Apolipoprotein B Levels. The American Journal of Human Genetics. 64(5). 1453–1463. 123 indexed citations
18.
Pajukanta, Päivi, Ilpo Nuotio, Joseph D. Terwilliger, et al.. (1998). Linkage of familial combined hyperlipidaemia to chromosome 1q21–q23. Nature Genetics. 18(4). 369–373. 217 indexed citations
19.
Nuotio, Ilpo, Päivi Pajukanta, Mikko Syvänne, et al.. (1997). Phenotype expression in familial combined hyperlipidemia. Atherosclerosis. 133(2). 245–253. 53 indexed citations
20.
Ylitalo, Kati, Kimmo Porkka, Seppo Meri, et al.. (1997). Serum complement and familial combined hyperlipidemia. Atherosclerosis. 129(2). 271–277. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tetsu Ebara Breakdown of academic impact, for papers by T W de Bruin Breakdown of academic impact, for papers by George J. Miller Breakdown of academic impact, for papers by Changting Haudenschild Breakdown of academic impact, for papers by Daniel Brun Breakdown of academic impact, for papers by JD Brunzell Breakdown of academic impact, for papers by Felicia Y. T. Yap Breakdown of academic impact, for papers by Ugo Cavallari Breakdown of academic impact, for papers by Sabine Rütti Breakdown of academic impact, for papers by M. Poapst
Rankless by CCL
2026